Ischemia reperfusion dysfunction changes model-estimated kinetics of myofilament interaction due to inotropic drugs in isolated hearts

BioMedical Engineering Online

Volumn 5, Issue , 2006, Pages

  Rhodes, Samhita S ^a   Camara, Amadou K S ^a   Ropella, Kristina M ^b   Audi, Said H ^a,b,c   Riess, Matthias L ^a   Pagel, Paul S ^a,b,c   Stowe, David F ^a,b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Medical College of Wisconsin and Marquette University   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUINEA PIG; ISCHEMIA REPERFUSION DYSFUNCTION; MODEL-ESTIMATED KINETICS;

ARTIFICIAL ORGANS; ESTIMATION; KINETIC THEORY; MATHEMATICAL MODELS;

BIOMEDICAL ENGINEERING;

CALCIUM ION; DIGOXIN; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; LEVOSIMENDAN; CALCIUM; CARDIOTONIC AGENT;

ANALYTICAL ERROR; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIASTOLE; DISSOCIATION; EXCITATION CONTRACTION COUPLING; GUINEA PIG; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; ISOLATED HEART; MATHEMATICAL MODEL; MYOFILAMENT; NONHUMAN; PREDICTION; REPERFUSION INJURY; ACTIN FILAMENT; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; COMPUTER ASSISTED DRUG THERAPY; COMPUTER SIMULATION; DOSE RESPONSE; DRUG EFFECTS; ETIOLOGY; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; KINETICS; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ANIMALIA; CAVIA PORCELLUS;

ACTIN CYTOSKELETON; ANIMALS; CALCIUM; CARDIOTONIC AGENTS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMPUTER-ASSISTED; GUINEA PIGS; KINETICS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; REPERFUSION INJURY; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645539806     PISSN: 1475925X     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-5-16     Document Type: Article

References (38)

1. Camara AK, Chen Q, Rhodes SS, Riess ML, Stowe DF: Negative inotropic drugs alter indices of cytosolic [Ca2+]-left ventricular pressure relationships after ischemia. Am J Physiol Heart Circ Physiol 2004, 287:H667-80.
2. Chen Q, Camara AKS, Rhodes SS, Riess ML, Novalija E, Stowe DF: Cardiotonic drugs differentially alter cytosolic [Ca2+] to left ventricular relationships before and after ischemia in isolated guinea pig hearts. Cardiovasc Res 2003, 59:912-925.
3. Rhodes SS, Ropella KM, Camara AKS, Chen Q, Riess ML, Stowe DF: How inotropic drugs alter dynamic and static indices of cyclic myoplasmic [Ca2+] to contractility relationships in intact hearts. J Cardiovasc Pharmacol 2003, 42:539-553.
4. Rhodes SS, Ropella KM, Audi SH, Camara AK, Kevin LG, Pagel PS, Stowe DF: Cross-bridge kinetics modeled from myoplasmic [Ca2+] and LV pressure at l7oC and after 37oC and 17oC ischemia. Am J Physiol Heart Circ Physiol 2003, 284:H1217-H1229.
5. Rhodes SS, Ropella KM, Camara AKS, Chen Q, Riess ML, Pagel PS, Stowe DF: Ischemia reperfusion injury changes the dynamics of Ca2+-contraction coupling due to inotropic drugs in isolated hearts. J Appl Physiol 2006, 100:940-950.
6. Campbell K: Rate constant of muscle force redevelopment reflects cooperative activation as well as cros-bridge kinetics. Biophys J 1997, 72:254-262.
7. Baran D, Ogino K, Stennett R, Schnellbacher M, Zwas D, Morgan J P, Burkhoff D: Interrelating of ventricular pressure and intracellular calcium in intact hearts. Am J Physiol Heart Circ Physiol 1997, 273:H1509-22.
8. Shimizu J, Todaka K, Burkhoff D: Load dependence of ventricular performance explained by model of calciunn-myofilament interactions. Am J Physiol Heart Circ Physiol 2002, 282:H1081-91.
9. Tanigawa T, Yano M, Kohno M, Yamamoto T, Hisaoka T, Ono K, Ueyama T, Kobayashi S, Hisamatsu Y, Ohkusa T, Matsuzaki M: Mechanism of preserved positive lusitropy by cAMP-dependent drugs in heart failure. Am J Physiol Heart Circ Physiol 2000, 278:H313-20.
10. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ: Phosphorylation of troponin 1 by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 2001, 88: 1059-1065.
11. Janssen PM, de Tombe PP: Protein kinase A does not alter unloaded velocity of sarcomere shortening in skinned rat cardiac trabeculae. Am J Physiol 1997, 273:H2415-22.
12. Fritz PJ, Hamrick ME, Lankford JC, Cho Y, Clark CE: The effect of digoxin on rat contractile proteins. 1. In vivo studies. Pharmacology 1968, 1:303-311.
13. Hasenfuss G, Mulieri LA, Allen PD, Just H, Alpert NR: Influence of isoproterenol and ouabain on excitation-contraction coupling, cross- bridge function, and energetics in failing human myocardium. Circulation 1996, 94:3155-3160.
14. Brixus K, Mehilhorn U, Bloch W, Schwinger RH: Different effect of the Ca2+ sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium. J Pharmacol Exp Ther 2000, 295:1284-1290.
15. Endoh M: Mechanisms of action of novel cardiotonic agents. J Cardiovasc Pharmacol 2002, 40:323-338.
16. Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Linden IB: Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995, 25:794-801.
17. Haikala H, Levijoki J, Linden IB: Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension. J Mol Cell Cardial 1995, 27:2155-2165.
18. Stowe DF, Varadarajan SG, An JZ, Smart SC: Reduced cytosolic Ca2+ loading and improved cardiac function after cardioplegic cold storage of guinea pig isolated hearts. Circulation 2000, 102:1172-1177.
19. Varadarajan SG, An JZ, Novalija E, Smart SC, Stowe DF: Changes in [Na+]i, compartmental [Ca2+], and NADH with dysfunction after global ischemia in intact hearts. Am J Physiol Heart Circ Physiol 2001, 280:H280-93.
20. Varadarajan SG, An JZ, Novalija E, Stowe DF: Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca2+ loading in intact hearts. Anesthesiology 2002, 96:125-133.
21. Chen Q, Camara AKS, An JZ, Riess ML, Novalija E, Stowe DF: Cardiac preconditioning with 4 h, 17oC ischemia reduces [Ca2+]i load and damage in part via KATP channel opening. Am J Physiol Heart Circ Physiol 2002, 282:H1961-H1969.
22. An JZ, Camara AKS, Chen Q, Stowe DF: Effect of low [CaC12] and high [MgC12] cardioplegia and moderate hypothermic ischemia on myoplasmic [Ca2+] and cardiac function in intact hearts. Eur J Cardiothorac Surg 2003, 24:974-985.
23. Camara AKS, Chen Q, An JZ, Novalija E, Riess ML, Rhodes SS, Stowe DF: Comparison of hyperkalemic cardioplegia with altered [CaC12] and [MgC12] on [Ca2+]i transients; and function after warm global ischemia in isolated hearts. J Cardiovasc Surg (Torino) 2004, 45:1-13.
24. Camara AKS, An JZ, Chen Q, Novalija E, Varadarajan SG, Schelling P, Stowe DF: Na+/H+ exchange inhibition with cardioplegia reduces cytosolic [Ca2+] and myocardial damage after cold ischemia. J Cardiovasc Pharmacol 2003, 41:686-698.
25. Burkhoff D: Explaining load dependence of ventricular contractile properties with a model of excitation-contraction coupling. J Mol Cell Cardiol 1994, 26:959-978.
26. Peterson JN, Hunter WC, Berman MR: Estimated time course of Ca2+ bound to troponin C during relaxation in isolated cardiac muscle. Am J Physiol Heart Circ Physiol 1991, 260:H1013-24.
27. Rice JJ, Jafri MS, Winslow RL: Modeling gain and gradedness of Ca2+ release in the functional unit of the cardiac diadic space. Biophys J 1999, 77:1871-1884.
28. Landesberg A, Sideman S: Mechanical regulation of cardiac muscle by coupling calcium kinetics with cross-bridge cycling: a dynamic model. Am J Physiol Heart Circ Physiol 1994, 267:H779-95.
29. Eisenberg E, Hill TL: Muscle contraction and free energy transduction in biological systems. Science 1985, 227:999-1006.
30. Kentish JC, Wrzosek A: Changes in force and cytosolic Ca2+ concentration after length changes in isolated rat ventricular trabeculae. J Physiol 1998, 506:431-444.
31. Hill TL Two elementary models for the regulation of skeletal muscle contraction by calcium. Biophys J 1983, 44:383-396.
32. Winslow RL, Rice J, Jafri S: Modeling the cellular basis of altered excitation-contraction coupling in heart failure. Prog Biophys Mot Biol 1998, 69:497-514.
33. Ch'en FF, Vaughan-Jones RD, Clarke K, Noble D: Modelling myocardial ischaemia and reperfusion. Prog Biophys Mol Biol 1998, 69:515-538.
34. Kaumann A, Bartel S, Molenaar P, Sanders L, Burrell K, Vetter D, Hempel P, Karczewski P, Krause EG: Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin 1, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation 1999, 99:65-72.
35. Endoh M, Blinks JR. Actions of sympathornimetic amines on the Ca2+ transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors. Circ Res 1988, 62:247-265.
36. Wahr PA, Metzger JM: Role of Ca2+ and cross-bridges in skeletal muscle thin filament activation probed with Ca2+ sensitizers. Biophys J 1999, 76:2166-2176.
37. Pagel PS, Haikala H, Pentikainen PJ, Toivonen ML, Nieminen MS, Lehtonen L, Papp JG, Warltier DC: Pharmacology of levosimendan: A new myofilament calcium sensitizer. Cardiovasc Drug Rev 1996, 14:286-316.
38. Campbell KB, Wu Y, Simpson AM, Kirkpatrick RD, Shroff SG, Granzier HL, Slinker BK: Dynamic myocardial contractile parameters from left ventricular pressure-volume measurements. Am J Physiol Heart Circ Physiol 2005, 289:H114-30.